These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7648066)

  • 21. Immunotargeting with monoclonal cytokeratin 8 antibodies of human urothelial cancer transplanted to nude mice.
    Letocha H; Nilsson S; Silén A; Ekblom J; Arnberg H; Wiklund B; Westlin JE
    Acta Oncol; 1993; 32(7-8):793-800. PubMed ID: 7508236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
    Kalofonos HP; Kosmas C; Hird V; Snook DE; Epenetos AA
    Eur J Cancer; 1994; 30A(12):1842-50. PubMed ID: 7880616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.
    Elsen S; Lerut E; Van Cleynenbreugel B; van der Aa F; van Poppel H; de Witte PA
    BJU Int; 2015 Sep; 116(3):468-77. PubMed ID: 25754262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy.
    Chinol M; De Cobelli O; Trifirò G; Scardino E; Bartolomei M; Verweij F; Papi S; Matei DV; Paganelli G
    Eur Urol; 2003 Nov; 44(5):556-9. PubMed ID: 14572754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
    Kramer EL; DeNardo SJ; Liebes L; Noz ME; Kroger L; Glenn SD; Furmanski P; Ceriani R
    Adv Exp Med Biol; 1994; 353():181-92. PubMed ID: 7985537
    [No Abstract]   [Full Text] [Related]  

  • 26. MUC1 mucin as a tumour marker in bladder cancer.
    Simms MS; Hughes OD; Limb M; Price MR; Bishop MC
    BJU Int; 1999 Aug; 84(3):350-2. PubMed ID: 10468735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoscintigraphy of colorectal cancer using a monoclonal antibody 77-1.
    Yiu CY; Baker LA; Davidson BR; McCready VR; Boulos PB
    Eur J Surg Oncol; 1991 Oct; 17(5):495-501. PubMed ID: 1936297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
    Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
    Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer.
    Russell PJ; Davis K; Kingsley E; Humphreys J; Hanley J; O'Grady H; Pearce N
    Cell Biophys; 1994; 24-25():155-61. PubMed ID: 7736520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Sivolapenko G; Skarlos DV; Serefoglou A; Lykourinas M; Proukakis C
    Cell Biophys; 1994; 24-25():75-81. PubMed ID: 7736542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistological findings in patients with superficial bladder carcinoma after intravesical instillation of keyhole limpet haemocyanin.
    Jurincic-Winkler C; Metz KA; Beuth J; Engelmann U; Klippel KF
    Br J Urol; 1995 Dec; 76(6):702-7. PubMed ID: 8535712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies.
    de Harven E; Fradet Y; Connolly JG; Hanna W; He S; Wang Y; Choi BC; McGroarty R; Bootsma G; Tilups A
    Cancer Res; 1992 Jun; 52(11):3131-7. PubMed ID: 1591726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of radioimmunoimaging with 99mTc-BDI-1 in the diagnosis of bladder cancer.
    Wang R; Zhang C; Yu L; Guo Y
    Chin Med J (Engl); 2000 May; 113(5):396-9. PubMed ID: 11776091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo localisation of human urinary bladder carcinoma xenograft in nude mice using radiolabelled monoclonal antibody.
    Yü DS; Yeh MY; Chen WL; Chang SY; Ma CP; Han SH
    Br J Urol; 1987 Jun; 59(6):540-6. PubMed ID: 3690186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.
    Ind TE; Granowska M; Britton KE; Morris G; Lowe DG; Hudson CN; Shepherd JH
    Br J Cancer; 1994 Dec; 70(6):1263-6. PubMed ID: 7981086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
    Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
    Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour localization of radiolabelled monoclonal antibody in mice bearing human urinary bladder (T24) carcinoma xenografts.
    Bubeník J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Novák F
    Folia Biol (Praha); 1985; 31(2):176-84. PubMed ID: 3894060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoimaging diagnosis of human bladder carcinoma.
    Yu LZ; Gu FL; Zhang CL
    Scand J Urol Nephrol Suppl; 1994; 157():13-7. PubMed ID: 7939444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
    Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
    Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.